"Big Pharma has been investing heavily in new technologies to aid drug development and it’s clear that the clinical trials of the future will involve a greater reliance on smart technologies, benefitting Pharma, but most importantly the patient too."
In his recent article with Global Health and Pharma, Dr. Andrew Rut, CEO of MyMeds&Me explores how technology is transforming modern-day clinical trials.
Read the article here.
